{"nct_id":"NCT02337738","title":"A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2015-01-27","start_date_type":"ACTUAL","primary_completion_date":"2016-09-17","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-17","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["TAK"]}